Cancer biotherapy & radiopharmaceuticals.

ISSN 1084-9785SAGE Publications LtdUnited States
ScopusMEDLINEEmbasePubMedPMCSCImagoJIFMatched via identifier

Journal overview

Titles
Cancer Biotherapy and Radiopharmaceuticals
Cancer Biother. Radiopharm. (abbreviated)
Cancer Biotherapy & Radiopharmaceuticals
Cancer Biother Radiopharm (abbreviated)
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS MARY ANN LIEBERT, INC
Cancer biotherapy & radiopharmaceuticals.
ISSN
1084-9785
1084-9785
eISSN
1557-8852
NLM ID
9605408
Publisher
SAGE Publications Ltd
Mary Ann Liebert Inc.
SAGE Publications
Larchmont, NY : Mary Ann Liebert, Inc., c1996-
Country
Language
ENG
English

Indexing & coverage

Scopus
Currently indexed

Scopus's Sources record lists this journal as active.

Indexing history
Coverage
1996–2026
Indexing services (MEDLINE, Embase)
MEDLINECurrently indexedEmbaseListed

Embase's Active journals record lists this journal as active.

Bibliographic inclusion (PubMed)
PubMedIncluded
Full-text availability (PMC — not an indexing service)
PMCCoverage available

Metrics

MetricYearValueQuartileRankSource
JIF20252.1Q27872JCR Impact Factor List 2025 — supplied dataset
SCImago Journal Rank (SJR) — 2025

Source: SCImago Journal & Country Rank — 2025 dataset. SJR is a metric published by SCImago, presented here as reported.

SJR
0.498
Best Quartile
Q2
H-index
74
Subject categories (quartile varies by category)
  • Radiology, Nuclear Medicine and Imaging — Q2
  • Medicine (miscellaneous) — Q3
  • Oncology — Q3
  • Pharmacology — Q3
  • Cancer Research — Q4
More metrics
Coverage
1996–2026
Country
United States
Region
Northern America
Publisher
Mary Ann Liebert Inc.
Open Access
No
Open Access (Diamond)
No
Total documents (current year)
110
Total documents (3 years)
259
Total references
5419
Total citations (3 years)
546
Citable documents (3 years)
254
Citations per document (2 years)
1.94
References per document
49.26
Source details
Match confidence
Confirmed — two independent ISSNs agree
Matched via ISSN(s)
1084-9785, 1557-8852
SCImago Source ID
28794
SCImago Rank (across all SCImago source types)
11927

Publication activity

Publication activity
2025
110 observed publications
Latest publication activity observed
2025
Current-year activity
Recent publication activity observed

Evidence sources: SCImago. SCImago's count is a source-reported aggregate figure; Crossref/OpenAlex/PubMed counts are distinct article records JCF Labs observed via each provider's own free API — none is guaranteed to be that journal's complete output for the year, and providers may disagree (this is expected, not an error). See this journal's own source evidence above for full context.

Subjects & categories

Subject area (SCImago)
MeSH (PubMed)
Biological Products/therapeutic use; Neoplasms/therapy; Radioisotopes/therapeutic use
Scopus:1996-2026
MEDLINE:MEDLINE: v15n1, Feb. 2000-; PubMed: v15n1, Feb. 2000-; Index medicus
PubMed:MEDLINE: v15n1, Feb. 2000-; PubMed: v15n1, Feb. 2000-; Index medicus
PMC:v.23(3) 2008 – v.39(10) 2024